Point72 Asset Management
EXAS

Point72 Asset Management’s Exact Sciences EXAS Stock Holding History

Point72 Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-371,800
Closed -$25.7M – 2022
2024
Q1 		$25.7M Buy
+371,800
New +$23.5M 0.06% 368

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Point72 Asset Management's EXAS Position: Q1 2026 in Review

Point72 Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 180,575 shares — an estimated $18.3M sold.

Point72 Asset Management first reported a position in EXAS in Q3 2014 and held it in 29 quarters. The position peaked at $136M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Point72 Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 180,575 Exact Sciences shares in Q1 2026, an estimated $18.3M.
  • Point72 Asset Management first reported a position in Exact Sciences in Q3 2014 and held it in 29 quarters.
  • Point72 Asset Management's Exact Sciences position peaked at $136M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.